Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.
about
The Photobiology of Lutein and Zeaxanthin in the EyeNutrient Supplementation for Age-related Macular Degeneration, Cataract, and Dry EyeA genetic dissection of intestinal fat-soluble vitamin and carotenoid absorptionDietary supplements and disease prevention - a global overview.Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular diseaseSystemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE studyVisual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degenerationThe Effect of a Mediterranean Diet on the Incidence of Cataract SurgeryPress releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study.Nutritional modulation of cataractInactivity of human β,β-carotene-9',10'-dioxygenase (BCO2) underlies retinal accumulation of the human macular carotenoid pigment.Topical nutraceutical Optixcare EH ameliorates experimental ocular oxidative stress in rats.Nutrition effects on ocular diseases in the aging eye.A dose-response meta-analysis of dietary lutein and zeaxanthin intake in relation to risk of age-related cataract.Ambiguities in dietary antioxidant supplementation compared to calcium channel blockers therapy.The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37Estimating cumulative pathway effects on risk for age-related macular degeneration using mixed linear models.Lutein Leads to a Decrease of Factor D Secretion by Cultured Mature Human Adipocytes.Healthy Eating Index in Patients With Cataract: A Case-Control Study.The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8Evaluation of optimized digital fundus reflex photographs for lens opacities in the age-related eye disease study 2: AREDS2 report 7'I'd like to know what causes it, you know, anything I've done?' Are we meeting the information and support needs of patients with macular degeneration? A qualitative studyThe Age-Related Macular Degeneration Complex: Linking Epidemiology and Histopathology Using the Minnesota Grading System (The Inaugural Frederick C. Blodi Lecture).Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians.Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina.The effect of multivitamin/mineral supplements on age-related cataracts: a systematic review and meta-analysisRecent developments in the treatment of age-related macular degeneration.Role of fatty acids and micronutrients in healthy ageing: a systematic review of randomised controlled trials set in the context of European dietary surveys of older adults.Risk factors and biomarkers of age-related macular degeneration.Carotenoids: biochemistry, pharmacology and treatment.Vitamin D and Age-Related Macular Degeneration.Ameliorative effects of SkQ1 eye drops on cataractogenesis in senescence-accelerated OXYS rats.Retinal accumulation of zeaxanthin, lutein, and β-carotene in mice deficient in carotenoid cleavage enzymes.The Evolving Role of Multivitamin/Multimineral Supplement Use among Adults in the Age of Personalized Nutrition.Recent Advances in Studies on the Therapeutic Potential of Dietary Carotenoids in Neurodegenerative Diseases.Lutein supplementation leads to decreased soluble complement membrane attack complex sC5b-9 plasma levelsThe Effect of Lutein on Eye and Extra-Eye Health
P2860
Q26769895-41C81C3C-6668-483A-89A1-626E97BA0397Q26821899-4D9E3539-8191-4323-AE8C-56DD3EE4DAFAQ28512836-A11DBF43-6D7E-4C89-AF02-9BAF2AE0C3D3Q30251418-6942BFA0-1916-4E30-98F7-82467800E312Q30693939-DB86F49D-8546-401B-BD8B-29A4B1392389Q33586908-37CDCE6D-ADD0-456F-BF12-27C1B0D43D42Q33717538-BEF684CE-E78A-4C9F-9CDD-525A52608D5FQ33739755-9057E425-F5F4-4958-9D30-B89EC66A7DA2Q33749282-3EBC753D-073C-4D7E-966A-7D3394096817Q33845330-25E9F6FC-6623-4D44-93A8-4EC4236455AEQ33900780-DA39F7EC-D5BC-4E2B-9307-C780BCAA27EAQ33925653-DBE4E87D-9973-4177-A859-18B3473FB693Q34116939-C6182649-40B8-47D2-8862-53A1AED0BD66Q34132062-36FF116C-EC31-4159-810D-03C7F7D39683Q34379644-64B5870E-A326-4280-8943-7880FE1F80C9Q35042122-9D65B97B-9282-4ED9-9F8B-B95EC4241AEAQ35798037-9C274CDB-D112-402A-8088-F2A3FB8B4BE5Q35807741-63F9D20B-5E04-430F-8C14-6999C87F1C8FQ36173190-D966A873-C48B-479C-BF6D-4C1ED82DD917Q36266713-248F2CCB-4BC1-4379-9173-0D6A70CB740AQ36730429-9BBA672B-AE0E-48B5-A98E-05CD78108098Q37166967-90DBEB9D-87E2-49A6-80CB-DACCE39FE002Q37293286-0B8528E3-847F-4CEA-BDE0-C6AFC52E84BDQ37412560-099EB9D5-449D-4BD6-A0C1-B8A342B69894Q37624757-12D7739A-4133-4D39-A7D4-CEE3BD61458CQ37645117-59DFB43F-E6B6-4768-8CD5-937A683C6939Q37666797-6AFA5915-1461-4C58-9041-1E17FBA5099DQ37679956-F0244D58-0026-4168-B138-FEA5118ABBB3Q38569301-8BB383F4-FDCC-423F-91E7-3541CFD3731EQ38828895-1E8C1EA3-F356-4D7C-9DAC-CDA8DCCD3502Q38957329-5332A21A-DAC9-49A1-94F7-DC54C6CE7963Q47100212-1A2E56D8-F676-4A2A-AAFA-0C38DEB3896CQ51048745-2A3CA543-55AD-401E-9F8E-3CE14B0F3247Q52782567-623ED4E2-8264-4E3B-84C6-5D57A2ECD1A4Q55224872-A052DD1E-8C18-4FE3-8EEE-73A5992B6378Q55246756-B8081EAC-BD39-4E5D-8F16-8EE13B5FEC7CQ57337541-2512D86B-77A4-419A-A57D-21FC4C8AF71EQ58722677-23C38041-6BFE-4139-9430-940501802769
P2860
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Lutein/zeaxanthin for the trea ...... randomized trial report no. 4.
@ast
Lutein/zeaxanthin for the trea ...... randomized trial report no. 4.
@en
Lutein/zeaxanthin for the trea ...... randomized trial report no. 4.
@nl
type
label
Lutein/zeaxanthin for the trea ...... randomized trial report no. 4.
@ast
Lutein/zeaxanthin for the trea ...... randomized trial report no. 4.
@en
Lutein/zeaxanthin for the trea ...... randomized trial report no. 4.
@nl
prefLabel
Lutein/zeaxanthin for the trea ...... randomized trial report no. 4.
@ast
Lutein/zeaxanthin for the trea ...... randomized trial report no. 4.
@en
Lutein/zeaxanthin for the trea ...... randomized trial report no. 4.
@nl
P2093
P1433
P1476
Lutein/zeaxanthin for the trea ...... randomized trial report no. 4
@en
P2093
Age-Related Eye Disease Study 2 (AREDS2) Research Group
Alan J Ruby
Amitha Domalpally
Andrew N Antoszyk
Barbara A Blodi
Cynthia A Toth
David Orth
Elvira Agron
Emily Y Chew
Frederick L Ferris
P304
P356
10.1001/JAMAOPHTHALMOL.2013.4412
P407
P577
2013-07-01T00:00:00Z